Epigenetic programming of μ-opioid receptor gene in mouse brain is regulated by MeCP2 and brg1 chromatin remodelling factor

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3591-3615

  Hwang, Cheol Kyu ^a   Song, Kyu Young ^a   Kim, Chun Sung ^a,b   Choi, Hack Sun ^a   Guo, Xiao Hong ^a   Law, Ping Yee ^a   Wei, Li Na ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Chosun University   (South Korea)

Author keywords

Chromatin remodelling; DNA methylation; Epigenetic regulation; Laser capture microdissection; MeCP2; Opioid receptor

Indexed keywords

HELICASE; HISTONE; METHYL CPG BINDING PROTEIN 2; MU OPIATE RECEPTOR; NUCLEAR PROTEIN; PRIMER DNA; SMARCA4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BRAIN; C57BL MOUSE; CHROMATIN; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PROMOTER REGION;

ANIMALS; BRAIN; CHROMATIN; CPG ISLANDS; DNA HELICASES; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, OPIOID, MU; TRANSCRIPTION FACTORS;

EID: 77449158988     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00535.x     Document Type: Article

References (47)

1. Law PY, Wong YH, Loh HH. Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol. 2000, 40:389-430.
2. Kieffer BL, Evans CJ. Opioid tolerance-in search of the holy grail. Cell. 2002, 108:587-90.
3. Mansour A, Fox CA, Akil H. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995, 18:22-9.
4. Gruenbaum Y, Stein R, Cedar H. Methylation of CpG sequences in eukaryotic DNA. FEBS Lett. 1981, 124:67-71.
5. Shiota K, Kogo Y, Ohgane J. Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells. 2002, 7:961-9.
6. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992, 69:915-26.
7. Berger SL. An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene. 2001, 20:3007-13.
8. Jones PL, Veenstra GJ, Wade PA. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998, 19:187-91.
9. Martinowich K, Hattori D, Wu H. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science. 2003, 302:890-3.
10. Hsieh CL. Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol. 1994, 14:5487-94.
11. Hagberg B, Aicardi J, Dias K. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol. 1983, 14:471-9.
12. Amir RE, Van den Veyver IB, Wan M. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999, 23:185-8.
13. Nan X, Ng HH, Johnson CA. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998, 393:386-9.
14. Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell. 1999, 99:451-4.
15. Fuks F, Hurd PJ, Wolf D. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem. 2003, 278:4035-40.
16. Kimura H, Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem. 2003, 278:4806-12.
17. Becker PB, Horz W. ATP-dependent nucleosome remodeling. Annu Rev Biochem. 2002, 71:247-73.
18. Lusser A, Kadonaga JT. Chromatin remodeling by ATP-dependent molecular machines. Bioessays. 2003, 25:1192-200.
19. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002, 108:475-87.
20. Peterson CL, Workman JL. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr Opin Genet Dev. 2000, 10:187-92.
21. Wang W, Cote J, Xue Y. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 1996, 15:5370-82.
22. Harikrishnan KN, Chow MZ, Baker EK. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet. 2005, 37:254-64.
23. Hu K, Nan X, Bird A. Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex. Nat Genet 2006, 38:962-4. author reply 4-7
24. Chen HC, Wei LN, Loh HH. Expression of mu-, kappa- and delta-opioid receptors in P19 mouse embryonal carcinoma cells. Neuroscience. 1999, 92:1143-55.
25. Hwang CK, Song KY, Kim CS. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol. 2007, 27:4720-36.
26. Choi HS, Hwang CK, Kim CS. Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene. Mol Pharmacol. 2005, 67:1674-83.
27. Paterno GD, Gillespie LL, Julien JP. Regulation of neurofilament L, M and H gene expression during retinoic acid-induced neural differentiation of P19 embryonal carcinoma cells. Brain Res Mol Brain Res. 1997, 49:247-54.
28. Song KY, Hwang CK, Kim CS. Translational repression of mouse mu opioid receptor expression via leaky scanning. Nucleic Acids Res. 2007, 35:1501-13.
29. Gilsbach R, Kouta M, Bonisch H. Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques. 2006, 40:173-7.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
31. Yamasaki K, Joh K, Ohta T. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet. 2003, 12:837-47.
32. Kim CS, Choi HS, Hwang CK. Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res. 2006, 34:6392-403.
33. Hwang CK, Kim CS, Choi HS. Transcriptional regulation of mouse mu opioid receptor gene by PU.1. J Biol Chem. 2004, 279:19764-74.
34. Kim CS, Hwang CK, Choi HS. Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem. 2004, 279:46464-73.
35. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
36. Drewell RA, Goddard CJ, Thomas JO. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Res. 2002, 30:1139-44.
37. Lachner M, Jenuwein T. The many faces of histone lysine methylation. Curr Opin Cell Biol. 2002, 14:286-98.
38. Jenuwein T, Allis CD. Translating the histone code. Science. 2001, 293:1074-80.
39. Nikulina EM, Hammer RP, Miczek KA. Social defeat stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental area. Neuroreport. 1999, 10:3015-9.
40. Nikulina EM, Miczek KA, Hammer RP. Prolonged effects of repeated social defeat stress on mRNA expression and function of mu-opioid receptors in the ventral tegmental area of rats. Neuropsychopharmacology. 2005, 30:1096-103.
41. Unterwald EM, Horne-King J, Kreek MJ. Chronic cocaine alters brain mu opioid receptors. Brain Res. 1992, 584:314-8.
42. Unterwald EM, Rubenfeld JM, Kreek MJ. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport. 1994, 5:1613-6.
43. Unterwald EM. Regulation of opioid receptors by cocaine. Ann N Y Acad Sci. 2001, 937:74-92.
44. Vecchiola A, Collyer P, Figueroa R. Differential regulation of mu-opioid receptor mRNA in the nucleus accumbens shell and core accompanying amphetamine behavioral sensitization. Brain Res Mol Brain Res. 1999, 69:1-9.
45. Mansour A, Fox CA, Burke S. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat. 1995, 8:283-305.
46. Ko JL, Minnerath SR, Loh HH. Dual promoters of mouse mu-opioid receptor gene. Biochem Biophys Res Commun. 1997, 234:351-7.
47. Min BH, Augustin LB, Felsheim RF. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc Natl Acad Sci USA. 1994, 91:9081-5.